10-Q: Bodhi Tree Biotechnology Q2 2026 Financials Show Revenue Growth

Bodhi Tree Biotechnology Inc. reported increased revenues for the second quarter of fiscal year 2026, though the company continues to operate at a net loss.

Summary

• Bodhi Tree Biotechnology Inc. filed its Form 10-Q for the quarter ended March 31, 2026.
• The company reported revenues of $15,000 for the three months ended March 31, 2026, an increase from $0 in the same period of the prior year.
• For the six months ended March 31, 2026, revenues were $15,000, up from $5,000 in the corresponding period of 2025.
• General and administrative expenses decreased to $42,934 for the three months ended March 31, 2026, from $52,179 in the prior year period.
• The net loss for the three months ended March 31, 2026, was $29,195, an improvement from a net loss of $53,428 in the prior year period.
• For the six months ended March 31, 2026, the net loss was $82,144, an improvement from $118,205 in the prior year period.
• Cash on hand decreased to $22,750 as of March 31, 2026, from $109,404 as of September 30, 2025.
• The company's application to have its common stock quoted on the OTCQB Venture Market was approved during the quarter.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to continued net losses, a significant decrease in cash, and material weaknesses in internal controls, despite some revenue growth.

Positives

• Revenue increased to $15,000 for the three months ended March 31, 2026, compared to $0 in the prior year period.
• Revenue for the six months ended March 31, 2026, increased to $15,000 from $5,000 in the prior year period.
• General and administrative expenses decreased for both the three-month and six-month periods ended March 31, 2026, compared to the prior year periods.
• Net loss improved to $29,195 for the three months ended March 31, 2026, from $53,428 in the prior year period.
• Net loss improved to $82,144 for the six months ended March 31, 2026, from $118,205 in the prior year period.
• The company's common stock was approved for quotation on the OTCQB Venture Market.

Negatives

• The company continues to incur net losses, with a loss of $29,195 for the three months and $82,144 for the six months ended March 31, 2026.
• Cash on hand significantly decreased from $109,404 as of September 30, 2025, to $22,750 as of March 31, 2026.
• The company identified material weaknesses in its internal controls over financial reporting, specifically a lack of US GAAP knowledge and segregation of duties.
• All revenue for the six months ended March 31, 2026, and 2025, came from a single customer, representing a concentration of risk.

Risks

• The company has a history of operating losses and an accumulated deficit of $293,763 as of March 31, 2026.
• The company's ability to continue as a going concern is dependent on its ability to achieve profitability or secure additional funding, which may not be available on acceptable terms.
• There is a concentration of risk as all revenue for the six months ended March 31, 2026, came from one individual customer.
• Material weaknesses in internal controls over financial reporting, including lack of US GAAP knowledge and segregation of duties, could lead to errors or fraud.
• The realization of deferred tax assets is uncertain due to potential limitations from ownership changes and the company's ability to generate future taxable income.

Future Outlook

The company plans to fund its operations through public offerings, private placements, or stock issuance until profitable operations are achieved. If necessary, alternative sources like loans or advances from officers, directors, or others may be sought. The company believes this plan provides an opportunity to continue as a going concern, but failure to achieve profitability or secure funding would be detrimental.

Management Comments

• Management believes that all adjustments considered necessary for a fair presentation of the financial position and the results of operations and cash flows for the interim periods have been included.
• Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.
• Management does not believe that any of the identified material weaknesses in internal controls materially affected the results and accuracy of its financial statements.
• Management has begun a review to improve the identified material weaknesses in internal controls.

Industry Context

StockSavvy.ai notes that Bodhi Tree Biotechnology Inc. operates in the plant-based food and wellness sector, a growing market driven by increasing consumer interest in health and sustainability. However, the company's current financial performance, characterized by revenue growth but continued net losses and a significant decrease in cash, highlights the challenges of early-stage companies in this sector to achieve profitability and scale.

Comparison to Industry Standards

• The company's revenue of $15,000 for the three months ended March 31, 2026, is very low compared to established players in the food technology and consulting sectors, which often report revenues in the millions or billions.
• The net loss of $29,195 for the quarter, while an improvement, is a common characteristic of early-stage companies investing in growth, but it contrasts with the profitability of mature companies in the industry.
• The significant decrease in cash reserves is a concern, as many companies in this sector rely on substantial funding rounds to sustain operations and R&D, unlike Bodhi Tree's current limited cash position.
• The identification of material weaknesses in internal controls is a red flag, as robust financial reporting and controls are standard expectations for publicly traded companies, even smaller ones, and are critical for investor confidence.

Corporate Governance

Legal Proceedings

• There is no material litigation, arbitration or governmental proceeding currently pending against the company or any members of its management team.

Related Party Transactions

• The company has a service agreement with BEEC Inc. for office rental, phone line, bookkeeping, accounting, facility maintenance, board of secretary services, and payment to a director.

Stakeholder Impact

• Shareholders: Continued net losses and decreasing cash reserves may impact stock value and future dilution if capital is raised. Approval for OTCQB listing is a positive development.
• Employees: The company's financial situation and internal control weaknesses could create uncertainty.
• Creditors: The company's liquidity position and ongoing losses may raise concerns about its ability to meet obligations, though no specific creditor impacts are detailed.
• Suppliers: Payment for services, such as those from BEEC Inc. and professional firms, is ongoing, with an accrual for a quarterly review fee.

Next Steps

• Continue to seek funding through public offerings, private placements, or other means to support operations.
• Work to improve internal controls over financial reporting, addressing the identified material weaknesses.
• Continue to develop and provide vegetarian menu and recipe designs and vegetarian diet consulting services.
• Monitor customer concentration risk and seek to diversify customer base.

Key Dates

Recommendation

The company shows revenue growth and improved net loss, which are positive signs. However, the significant decrease in cash, material weaknesses in internal controls, and reliance on a single customer present substantial risks. A 'hold' recommendation reflects a cautious approach, awaiting further evidence of sustainable growth, improved financial controls, and a stronger liquidity position.

Keywords

Bodhi Tree Biotechnology, 10-Q, Quarterly Report, Financial Statements, Revenue, Net Loss, Biotechnology, SEC Filing, OTCQB, Internal Controls